Cutler Group LP Standard Biotools Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.6 - $3.99 $2,313 - $5,769	-1,446 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$3.63 - $6.13 $27,225 - $45,975	-7,500 Reduced 83.84%	1,446 $5,000
Q3 2021 Oct 26, 2021	SELL	$5.5 - $7.41 $53,487 - $72,062	-9,725 Reduced 52.09%	8,946 $58,000
Q1 2021 Apr 26, 2021	BUY	$3.94 - $7.09 $20,889 - $37,591	5,302 Added 39.66%	18,671 $84,000
Q4 2020 Jan 21, 2021	SELL	$5.45 - $8.65 $242,732 - $385,253	-44,538 Reduced 76.91%	13,369 $80,000
Q3 2020 Oct 27, 2020	BUY	$4.34 - $11.43 $251,316 - $661,877	57,907 New	57,907 $430,000
Q4 2017 Jan 17, 2018	SELL	$4.46 - $6.45 $20,832 - $30,127	-4,671 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$3.55 - $5.49 $16,582 - $25,643	4,671	4,671 $23,000

143

276M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $122M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.